Form 4: Artivion VP Regulatory Sells Shares Under 10b5-1 Trading Plan

Andrew M. Green, VP of Regulatory at Artivion, Inc., sold 7,618 shares of common stock at $30 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Andrew M. Green, Vice President of Regulatory at Artivion, Inc., sold 7,618 shares of the company's common stock on December 4, 2024.
• The shares were sold at a price of $30 per share.
• This transaction was executed under a pre-established 10b5-1 trading plan adopted by Mr. Green on August 13, 2024.
• Following the sale, Mr. Green directly owns 33,503 shares of Artivion common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine insider sale under a pre-arranged plan, which is neither particularly positive nor negative.

Risks

• Sales by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and sales under 10b5-1 plans are generally viewed as pre-planned and not necessarily indicative of a negative outlook on the company.

Comparison to Industry Standards

• Sales by executives are common and are often part of their overall compensation and financial planning.
• The use of 10b5-1 trading plans is a standard practice to avoid accusations of insider trading, and many executives at similar companies use these plans.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

Keywords

insider trading, Form 4, 10b5-1 trading plan, stock sale, Artivion, AORT, Andrew M. Green, VP Regulatory